[go: up one dir, main page]

ES2156938T3 - Forma de presentacion transdermica de nitroglicerina para impedir una indeseada actividad de contracciones del parto. - Google Patents

Forma de presentacion transdermica de nitroglicerina para impedir una indeseada actividad de contracciones del parto.

Info

Publication number
ES2156938T3
ES2156938T3 ES95911253T ES95911253T ES2156938T3 ES 2156938 T3 ES2156938 T3 ES 2156938T3 ES 95911253 T ES95911253 T ES 95911253T ES 95911253 T ES95911253 T ES 95911253T ES 2156938 T3 ES2156938 T3 ES 2156938T3
Authority
ES
Spain
Prior art keywords
nitroglycerine
indeseated
transdermic
contractions
presentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95911253T
Other languages
English (en)
Inventor
Hans-Michael Wolff
Dietrich Schacht
Martin Feelisch
Bruce Academic Dept Of Ramsay
John Francis The Wellco Martin
Christoph Christopher Dep Lees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma GmbH
Original Assignee
Schwarz Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwarz Pharma AG filed Critical Schwarz Pharma AG
Application granted granted Critical
Publication of ES2156938T3 publication Critical patent/ES2156938T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION FARMACEUTICA DE NITROGLICERINA TAMBIEN DESCRITA COMO TRINITRATO DE GLICEROL O QUIMICAMENTE COMO TRINITRATO DE 1,2,3 ORMA DE APLICACION TRANSDERMICA. LA UTILIZACION CONFORME A LA INVENCION PREVIENE PARTOS NO DESEADOS EN MAMIFEROS GESTANTES. LA UTILIZACION FARMACEUTICA SIRVE PARA PROFILAXIS DE PARTOS PREMATUROS.
ES95911253T 1994-02-28 1995-02-23 Forma de presentacion transdermica de nitroglicerina para impedir una indeseada actividad de contracciones del parto. Expired - Lifetime ES2156938T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4406332A DE4406332C1 (de) 1994-02-28 1994-02-28 Pharmazeutische Verwendung von Nitroglycerin zur Verhinderung unerwünschter Wehentätigkeit bei Säugern in einer transdermalen Applikationsform

Publications (1)

Publication Number Publication Date
ES2156938T3 true ES2156938T3 (es) 2001-08-01

Family

ID=6511303

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95911253T Expired - Lifetime ES2156938T3 (es) 1994-02-28 1995-02-23 Forma de presentacion transdermica de nitroglicerina para impedir una indeseada actividad de contracciones del parto.

Country Status (15)

Country Link
US (1) US5817697A (es)
EP (1) EP0804176B1 (es)
JP (1) JP2823700B2 (es)
KR (1) KR100334372B1 (es)
CN (1) CN1069522C (es)
AT (1) ATE200732T1 (es)
CA (1) CA2184201A1 (es)
DE (2) DE4406332C1 (es)
DK (1) DK0804176T3 (es)
ES (1) ES2156938T3 (es)
FI (1) FI963329L (es)
GR (1) GR3035785T3 (es)
NO (1) NO961724L (es)
PT (1) PT804176E (es)
WO (1) WO1995022964A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020015951A1 (en) * 2000-01-06 2002-02-07 Bader Joel S. Method of analyzing a nucleic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239318A (en) * 1983-04-27 1988-07-19 Hans R. Hoffmann Pharmaceutical product preferably in medical bandage form and process for producing them
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
KR0165875B1 (ko) * 1991-06-10 1999-01-15 . 니트로글리세린 플래스터 및 그의 제조방법
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
JPH1192367A (ja) * 1997-09-22 1999-04-06 Hoechst Marion Roussel Kk 妊娠悪阻治療剤

Also Published As

Publication number Publication date
KR100334372B1 (ko) 2002-09-04
WO1995022964A1 (de) 1995-08-31
US5817697A (en) 1998-10-06
CN1069522C (zh) 2001-08-15
DE4406332C1 (de) 1995-06-22
GR3035785T3 (en) 2001-07-31
NO961724D0 (no) 1996-04-29
EP0804176A1 (de) 1997-11-05
JP2823700B2 (ja) 1998-11-11
ATE200732T1 (de) 2001-05-15
DE59509223D1 (de) 2001-05-31
FI963329L (fi) 1996-09-05
JPH09506108A (ja) 1997-06-17
KR960705553A (ko) 1996-11-08
NO961724L (no) 1996-04-29
FI963329A0 (fi) 1996-08-27
EP0804176B1 (de) 2001-04-25
CA2184201A1 (en) 1995-08-31
CN1140990A (zh) 1997-01-22
DK0804176T3 (da) 2001-05-28
PT804176E (pt) 2001-08-30

Similar Documents

Publication Publication Date Title
SE8202172L (sv) Topiska farmaceutiska kompositioner
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
ES2130420T3 (es) Preparado transdermico de sustancia activa.
NO2012015I1 (no) Dapoxetine i en hver form beskyttet av basis patent nr 330562
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
CL2008003938A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
DE60143911D1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
ATE239709T1 (de) Racemisches huperzin a
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
TR199802769T2 (xx) Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim.
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
ATE78031T1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
ES2159362T3 (es) Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica.
IT1318667B1 (it) Medicamento antinfiammatorio.
RS52011B (sr) Nova primena derivata taksoida
ES2156938T3 (es) Forma de presentacion transdermica de nitroglicerina para impedir una indeseada actividad de contracciones del parto.
SE0000303D0 (sv) Novel compounds
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
TR199901206T2 (xx) Diyabetik damar rahats�zl�klar�n�n �nlenmesi i�in bir ila� �retiminde katekol-O-metil transferaz inhibit�rlerinin kullan�lmas�.
HN2000000090A (es) Sal difosfato de un derivado de 4sustituido-9-desoxo-9a-aza-9a-homoeritromicina y su composicion farmaceutica.
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
ES2032572T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica para aplicacion topica sobre la piel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 804176

Country of ref document: ES